Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurovirol ; 29(3): 358-363, 2023 06.
Artigo em Inglês | MEDLINE | ID: mdl-37171751

RESUMO

Hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide. In rare cases, HEV may generate neurologic lesions such as neuralgic amyotrophy, Guillain-Barré syndrome, and meningoencephalitis. Thirteen cases of HEV meningoencephalitis have been reported over 20 years. The clinical landscape varied from mild symptoms to coma and seizures. Most of patients were immunocompetent adults and spontaneously recovered. We report here the case of a 44-year-old immunocompetent adult with HEV meningoencephalitis presenting with aggressiveness and then coma. The evolution was spontaneously favorable without any specific treatment. This clinical case aims to draw attention on this emerging and probably under-recognized cause of meningoencephalitis.


Assuntos
Encefalite , Vírus da Hepatite E , Hepatite E , Meningoencefalite , Raiva , Adulto , Humanos , Anticorpos , Coma , Confusão , Ácido D-Aspártico , Hepatite E/diagnóstico
2.
Ann Biol Clin (Paris) ; 68(4): 465-72, 2010.
Artigo em Francês | MEDLINE | ID: mdl-20650742

RESUMO

The newly developed, high throughput, Vitros 3600 immunoassay system associates different technologies on board: MicroWell (analytes immunocapture), MicroSensor (visible interference analysis), and Intellicheck (real time process control for analytical error detection). During a three months period, Vitros 3600 system, ease of use, practicability and MicroSensor technology efficiency have been tested using the following assays: betaHCG, troponin, ferritin, aHBcT, HBsAg, aHCV, AFP and CEA. Within-day and within-batch, between-calibration precisions are acceptable. Overall assay correlations versus the methods in use in our laboratory are good, despite small numerical differences that never affect clinical interpretation of the results. We have appreciated the system reliability, reinforced by the ease of use (simple software, on-board VDocs, continuous access to reagent and sample loading, reagent stability, very low noise (60 dB)), the quality of the results, MicroSensor and Intellicheck technologies efficiency, the short maintenance time and its traceability, and the very low liquid waste volume (5 L of liquid waste for 1600 tests). In conclusion and considering its practicability, the Vitros 3600 system is fully validated and well suited for our laboratory.


Assuntos
Imunoensaio/métodos , Análise Química do Sangue/métodos , Calibragem , Antígeno Carcinoembrionário/sangue , Ferritinas/sangue , Antígenos de Superfície da Hepatite B/sangue , Humanos , Hidrocortisona/sangue , Imunoensaio/instrumentação , Indicadores e Reagentes , Reprodutibilidade dos Testes , Troponina/sangue , alfa-Fetoproteínas/análise
3.
Int J STD AIDS ; 18(9): 593-5, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17785000

RESUMO

Both herpes simplex virus type 2 (HSV-2) seroprevalence and the proportion of HSV-1 genital ulcers are increasing in industrialized countries. The consequences of these epidemiological changes, in pregnant women in France, for both the genital shedding of HSV and vertical transmission, have been poorly evaluated. The HSV-1 and HSV-2 seroprevalence and the rate of subclinical genital shedding of herpes close to delivery were evaluated in pregnant women, with no history of genital herpes, living in the East Paris suburban area. HSV-2 antibody prevalence of 26% was significantly associated with country of origin and was higher than that reported in 2002 in French women from the general population (18%). HSV-2 and HSV-1 genital reactivations were observed in 10% of HSV-2 seropositive and in 4% of HSV-1 seropositive and HSV-2 seronegative women, respectively. The high rates of HSV-2 seropositivity and subclinical herpes genital shedding observed in this study should be considered to promote a national survey in pregnant women to propose strategies to prevent the spread of HSV within the population and to the neonate.


Assuntos
Herpes Genital/epidemiologia , Herpesvirus Humano 2/patogenicidade , Eliminação de Partículas Virais , Adulto , Estudos de Coortes , Emigração e Imigração , Feminino , Humanos , Pessoa de Meia-Idade , Paris/epidemiologia , Gravidez , Prevalência , Estudos Soroepidemiológicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...